Literature DB >> 23266367

Small and colorful stones make beautiful mosaics: fragment-based chemogenomics.

Chris de Graaf1, Henry F Vischer, Gerdien E de Kloe, Albert J Kooistra, Saskia Nijmeijer, Martien Kuijer, Mark H P Verheij, Paul J England, Jacqueline E van Muijlwijk-Koezen, Rob Leurs, Iwan J P de Esch.   

Abstract

Smaller stones with a wide variety of colors make a higher resolution mosaic. In much the same way, smaller chemical entities that are structurally diverse are better able to interrogate protein binding sites. This feature article describes the construction of a diverse fragment library and an analysis of the screening of six representative protein targets belonging to three diverse target classes (G protein-coupled receptors ADRB2, H1R, H3R, and H4R, the ligand-gated ion channel 5-HT3R, and the kinase PKA) using chemogenomics approaches. The integration of experimentally determined bioaffinity profiles across related and unrelated protein targets and chemogenomics analysis of fragment binding and protein structure allow the identification of: (i) unexpected similarities and differences in ligand binding properties, and (ii) subtle ligand affinity and selectivity cliffs. With a wealth of fragment screening data being generated in industry and academia, such approaches will contribute to a more detailed structural understanding of ligand-protein interactions.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266367     DOI: 10.1016/j.drudis.2012.12.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  9 in total

1.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 2.  Twenty years on: the impact of fragments on drug discovery.

Authors:  Daniel A Erlanson; Stephen W Fesik; Roderick E Hubbard; Wolfgang Jahnke; Harren Jhoti
Journal:  Nat Rev Drug Discov       Date:  2016-07-15       Impact factor: 84.694

Review 3.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

Review 4.  The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures.

Authors:  Albert J Kooistra; Chris de Graaf; Henk Timmerman
Journal:  Neurochem Res       Date:  2014-08-08       Impact factor: 3.996

5.  KLIFS: a structural kinase-ligand interaction database.

Authors:  Albert J Kooistra; Georgi K Kanev; Oscar P J van Linden; Rob Leurs; Iwan J P de Esch; Chris de Graaf
Journal:  Nucleic Acids Res       Date:  2015-10-22       Impact factor: 16.971

6.  Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets.

Authors:  Gerard Jp van Westen; Remco F Swier; Isidro Cortes-Ciriano; Jörg K Wegner; John P Overington; Adriaan P Ijzerman; Herman Wt van Vlijmen; Andreas Bender
Journal:  J Cheminform       Date:  2013-09-24       Impact factor: 5.514

7.  Biofragments: an approach towards predicting protein function using biologically related fragments and its application to Mycobacterium tuberculosis CYP126.

Authors:  Sean A Hudson; Ellene H Mashalidis; Andreas Bender; Kirsty J McLean; Andrew W Munro; Chris Abell
Journal:  Chembiochem       Date:  2014-03-03       Impact factor: 3.164

8.  A fluorescent approach for identifying P2X1 ligands.

Authors:  Marc-David Ruepp; James A Brozik; Iwan J P de Esch; Richard W Farndale; Ruth D Murrell-Lagnado; Andrew J Thompson
Journal:  Neuropharmacology       Date:  2015-05-28       Impact factor: 5.250

9.  Fragment Screening Yields a Small-Molecule Stabilizer of 14-3-3 Dimers That Modulates Client Protein Interactions.

Authors:  Hendrik J Brink; Rick Riemens; Stephanie Thee; Berend Beishuizen; Daniel da Costa Pereira; Maikel Wijtmans; Iwan de Esch; Martine J Smit; Albertus H de Boer
Journal:  Chembiochem       Date:  2022-07-19       Impact factor: 3.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.